A molecular pathway inhibitor that inhibits tumor growth in an orthotopic model of invasive pancreatic cancer

被引：0
|
作者：
Cashman, John [1 ,2 ]
Okolotowicz, Karl [1 ,2 ]
Cheng, Jiongjia [2 ]
Lowy, Andrew M. [3 ]
Mercola, Mark [1 ,4 ]
机构：
[1] ChemRegen Inc, San Diego, CA USA
[2] Human BioMol Res Inst, San Diego, CA USA
[3] Univ Calif San Diego, Dept Surg, Moores Canc Ctr, Div Surg Oncol, La Jolla, CA 92093 USA
[4] Sanford Burnham Med Res Inst, Dev Aging & Regenerat Program, San Diego, CA USA
来源：
DRUG METABOLISM REVIEWS | 2016年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P64
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [1] Inhibition of Tumor Growth in an Orthotopic Model of Invasive Pancreatic Cancer: A Novel Molecular Pathway Inhibitor
    Cheng, Jiongjia
    Okolotowicz, Karl
    Lowy, Andrew M.
    Mercola, Mark
    Cashman, John
    FASEB JOURNAL, 2016, 30
  • [2] Curcumin Inhibits Tumor Growth and Angiogenesis in an Orthotopic Mouse Model of Human Pancreatic Cancer
    Bimonte, Sabrina
    Barbieri, Antonio
    Palma, Giuseppe
    Luciano, Antonio
    Rea, Domenica
    Arra, Claudio
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [3] Trametinib in Combination with Panitumumab and Trastuzumab Inhibits Tumor Growth in an Orthotopic Xenograft Model of Human Pancreatic Cancer
    Lindberg, J. M.
    Adair, S. J.
    Newhook, T. E.
    Kim, A.
    Parsons, J.
    Bauer, T. W.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S135 - S135
  • [4] The oral Multi-target Tumor Growth Inhibitor™, Zk 304700, inhibits growth of pancreatic neuroendocrine tumors in an orthotopic mouse model
    Scholz, Arne
    Wagner, Karola
    Welzel, Martina
    Wiedenmann, Bertram
    Rosewicz, Stefan
    Siemeister, Gerhard
    Detjen, Katharina M.
    GASTROENTEROLOGY, 2006, 130 (04) : A133 - A133
  • [5] Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model
    Büchler, P
    Reber, HA
    Lavey, RS
    Tomlinson, J
    Büchler, MW
    Friess, H
    Hines, OJ
    JOURNAL OF SURGICAL RESEARCH, 2004, 120 (02) : 295 - 303
  • [6] Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer
    Daman, Zahra
    Faghihi, Homa
    Montazeri, Hamed
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (09) : 1434 - 1442
  • [7] IAP (inhibitor of apoptosis) antagonist inhibits orthotopic lung tumor growth
    Jin, Hongkui
    Yang, Renhui
    Ho, Calvin
    Carano, Richard
    Musterer, Randy
    Eastham-Anderson, Jeffrey
    Komuves, Laszlo
    Zheng, Zhong
    Zha, Aping
    Fairbrother, Wayne
    Flygare, John
    Doerner, Karl
    Colbern, Gail
    Murray, Lesley
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3428S - 3429S
  • [8] The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model
    Scholz, A.
    Wagner, K.
    Welzel, M.
    Remlinger, F.
    Wiedenmann, B.
    Siemeister, G.
    Rosewicz, S.
    Detjen, K. M.
    GUT, 2009, 58 (02) : 261 - 270
  • [9] Inhibition of hepatocyte growth factor signaling pathway in combination with chemotherapy reduces tumor burden in an orthotopic model of advanced pancreatic cancer
    Xu, Z.
    Pang, T.
    Pothula, S.
    Mekapogu, A.
    Perera, C.
    Murakami, T.
    Goldstein, D.
    Pirola, R.
    Wilson, J.
    Apte, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 37 - 38
  • [10] Silibinin Inhibits Tumor Growth in a Murine Orthotopic Hepatocarcinoma Model and Activates the TRAIL Apoptotic Signaling Pathway
    Bousserouel, Souad
    Bour, Gaetan
    Kauntz, Henriette
    Gosse, Francine
    Marescaux, Jacques
    Raul, Francis
    ANTICANCER RESEARCH, 2012, 32 (07) : 2455 - 2462
12345